-
Je něco špatně v tomto záznamu ?
Helquat dyes targeting G-quadruplexes as a new class of anti-HIV-1 inhibitors
M. Pávová, PE. Reyes-Gutiérrez, J. Kozák, J. Dobiaš, Y. Yurenko, M. Lepšík, F. Teplý, J. Weber
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články, práce podpořená grantem
NLK
Directory of Open Access Journals
od 2011
Free Medical Journals
od 2011
Nature Open Access
od 2011-12-01
PubMed Central
od 2011
Europe PubMed Central
od 2011
ProQuest Central
od 2011-01-01
Open Access Digital Library
od 2011-01-01
Open Access Digital Library
od 2011-01-01
Health & Medicine (ProQuest)
od 2011-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2011
Springer Nature OA/Free Journals
od 2011-12-01
- MeSH
- G-kvadruplexy * MeSH
- HIV-1 * genetika MeSH
- koncové repetice MeSH
- promotorové oblasti (genetika) MeSH
- reverzní transkripce MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
The secondary structure of nucleic acids containing quartets of guanines, termed G-quadruplexes, is known to regulate the transcription of many genes. Several G-quadruplexes can be formed in the HIV-1 long terminal repeat promoter region and their stabilization results in the inhibition of HIV-1 replication. Here, we identified helquat-based compounds as a new class of anti-HIV-1 inhibitors that inhibit HIV-1 replication at the stage of reverse transcription and provirus expression. Using Taq polymerase stop and FRET melting assays, we have demonstrated their ability to stabilize G-quadruplexes in the HIV-1 long-terminal repeat sequence. Moreover, these compounds were not binding to the general G-rich region, but rather to G-quadruplex-forming regions. Finally, docking and molecular dynamics calculations indicate that the structure of the helquat core greatly affects the binding mode to the individual G-quadruplexes. Our findings can provide useful information for the further rational design of inhibitors targeting G-quadruplexes in HIV-1.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc23010442
- 003
- CZ-PrNML
- 005
- 20230801132429.0
- 007
- ta
- 008
- 230718s2023 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1038/s41598-023-33263-3 $2 doi
- 035 __
- $a (PubMed)37055553
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Pávová, Marcela $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Prague, 160 00, Czech Republic
- 245 10
- $a Helquat dyes targeting G-quadruplexes as a new class of anti-HIV-1 inhibitors / $c M. Pávová, PE. Reyes-Gutiérrez, J. Kozák, J. Dobiaš, Y. Yurenko, M. Lepšík, F. Teplý, J. Weber
- 520 9_
- $a The secondary structure of nucleic acids containing quartets of guanines, termed G-quadruplexes, is known to regulate the transcription of many genes. Several G-quadruplexes can be formed in the HIV-1 long terminal repeat promoter region and their stabilization results in the inhibition of HIV-1 replication. Here, we identified helquat-based compounds as a new class of anti-HIV-1 inhibitors that inhibit HIV-1 replication at the stage of reverse transcription and provirus expression. Using Taq polymerase stop and FRET melting assays, we have demonstrated their ability to stabilize G-quadruplexes in the HIV-1 long-terminal repeat sequence. Moreover, these compounds were not binding to the general G-rich region, but rather to G-quadruplex-forming regions. Finally, docking and molecular dynamics calculations indicate that the structure of the helquat core greatly affects the binding mode to the individual G-quadruplexes. Our findings can provide useful information for the further rational design of inhibitors targeting G-quadruplexes in HIV-1.
- 650 12
- $a G-kvadruplexy $7 D054856
- 650 _2
- $a promotorové oblasti (genetika) $7 D011401
- 650 _2
- $a koncové repetice $7 D020079
- 650 _2
- $a reverzní transkripce $7 D048348
- 650 12
- $a HIV-1 $x genetika $7 D015497
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Reyes-Gutiérrez, Paul Eduardo $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Prague, 160 00, Czech Republic
- 700 1_
- $a Kozák, Jaroslav $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Prague, 160 00, Czech Republic
- 700 1_
- $a Dobiaš, Juraj $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Prague, 160 00, Czech Republic
- 700 1_
- $a Yurenko, Yevgen $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Prague, 160 00, Czech Republic
- 700 1_
- $a Lepšík, Martin $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Prague, 160 00, Czech Republic
- 700 1_
- $a Teplý, Filip $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Prague, 160 00, Czech Republic
- 700 1_
- $a Weber, Jan $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Prague, 160 00, Czech Republic. jan.weber@uochb.cas.cz
- 773 0_
- $w MED00182195 $t Scientific reports $x 2045-2322 $g Roč. 13, č. 1 (2023), s. 6096
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/37055553 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20230718 $b ABA008
- 991 __
- $a 20230801132426 $b ABA008
- 999 __
- $a ok $b bmc $g 1963078 $s 1196707
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2023 $b 13 $c 1 $d 6096 $e 20230413 $i 2045-2322 $m Scientific reports $n Sci Rep $x MED00182195
- LZP __
- $a Pubmed-20230718